Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items

What comes next: A fairer approach to primary assessment
England’s primary school accountability and assessment system is not working well for disadvantaged children.
A durable majority?: How public opinion on the EU performs under pressure
A decade on from Brexit, Andy Burnham has signalled that a reassessment of the UK’s relationship with the EU might be around the corner.
New world, new relationship: Our future with Europe
Britain’s assumptions about its place in the world no longer hold, upturned by Russian aggression, American unreliability and Chinese coercion.